{"nct_id":"NCT00303472","title":"Determination of Safe Dose of Romiplostim (AMG 531) in Patients With Myelodysplastic Syndromes (MDS)","status":"COMPLETED","status_verified_date":"2013-11","start_date":"2006-02","start_date_type":null,"primary_completion_date":"2008-05","primary_completion_date_type":"ACTUAL","completion_date":"2008-05","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["AMGN"]}